Duke Medicine’s Health News (HN)


Volume 26   •   Number 11  •  November 2020

Blood Test Represents Giant Leap Forward for Alzheimer’s Research

Alzheimer’s disease, which causes progressive decline in memory and cognition, currently affects over 5 million people in the U.S., and about 20 million worldwide. There are several drugs approved by the FDA that treat the symptoms of Alzheimer’s disease by temporarily helping memory and thinking problems. However, these medications do not …


Issue Highlights

Enter Your Login Credentials
This setting should only be used on your home or work computer.

×